Oct 10, 2018 (China Knowledge) - Medopad, a London based medical company, has teamed up with Chinese tech giant Tencent to use artificial intelligence (AI) to diagnose Parkinson’s disease, British Broadcasting Corporation (BBC) reported yesterday.
There are more than 10 million Parkinson's patients in the world, 30% of them are from China. Moreover, the number of patients is on the rise with more than 100,000 new patients every year in China.
Early detection can significantly improve treatment outcomes, but detection of Parkinson's disease is no so easy.
Fan Wei, the leader of Tencent's medical AI laboratory, has said that their goal is to allow doctors to provide prescriptions and adjust treatment plans without patients having to go to hospital. Medical treatment is increasingly happening not just in hospital, but in everyday life. In addition, the main reason why Tencent want to work with Medopad is that they are experts in monitoring patients.
On the other hand, Medopad's CEO Dan Vahdat said, the partnership with Tencent is based on the vision of both sides to work together to improve healthcare services. By combining Medopad's expertise with Tencent's technical capabilities, Vahdat hopes to provide doctors with technology that can predict complications in patients with Parkinson's disease. In the face of the challenges of multiple diseases, they are working together to extend the lives of people with Parkinson's disease.
At present the system, jointly developed by Tencent and Medopad, can use AI technology to capture the way patients move their hands through cameras to determine the severity of symptoms.
Copyright © 2018 www.chinaknowledge.com
Send feedback or comments to: firstname.lastname@example.org
For more news, financial weekly reports, business guides to China and other premium information, subscribe to China Knowledge today: www.chinaknowledge.com
To access our page on Bloomberg, type CKFI